Hideki Mochizuki

17.4k total citations
436 papers, 11.4k citations indexed

About

Hideki Mochizuki is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hideki Mochizuki has authored 436 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Neurology, 137 papers in Molecular Biology and 104 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hideki Mochizuki's work include Parkinson's Disease Mechanisms and Treatments (116 papers), Neurological disorders and treatments (52 papers) and Neuroinflammation and Neurodegeneration Mechanisms (43 papers). Hideki Mochizuki is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (116 papers), Neurological disorders and treatments (52 papers) and Neuroinflammation and Neurodegeneration Mechanisms (43 papers). Hideki Mochizuki collaborates with scholars based in Japan, United States and United Kingdom. Hideki Mochizuki's co-authors include Yoshikuni Mizuno, Toru Yasuda, Chi‐Jing Choong, Masafumi Onodera, M. Yamada, Manabu Sakaguchi, Nobutaka Hattori, Hideo Mori, Kousuke Baba and Keigo Goto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hideki Mochizuki

417 papers receiving 11.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Mochizuki Japan 57 3.8k 3.8k 2.9k 1.9k 1.8k 436 11.4k
Manho Kim South Korea 60 6.3k 1.6× 2.7k 0.7× 3.1k 1.1× 1.5k 0.8× 1.4k 0.7× 302 12.8k
Axel Petzold United Kingdom 58 3.1k 0.8× 5.7k 1.5× 1.6k 0.5× 1.4k 0.7× 1.5k 0.9× 287 13.4k
Robert M. Friedlander United States 59 6.7k 1.8× 4.0k 1.0× 5.1k 1.8× 2.4k 1.2× 1.8k 1.0× 215 14.7k
Fredrik Piehl Sweden 64 3.7k 1.0× 4.1k 1.1× 2.5k 0.9× 2.0k 1.0× 1.5k 0.8× 324 15.1k
Linda J. Noble‐Haeusslein United States 57 4.5k 1.2× 4.2k 1.1× 2.7k 1.0× 1.6k 0.8× 1.1k 0.6× 132 13.5k
Daniel Offen Israel 59 5.4k 1.4× 2.5k 0.6× 3.1k 1.1× 1.2k 0.6× 1.4k 0.7× 211 11.5k
Hidehiro Mizusawa Japan 56 6.3k 1.6× 4.3k 1.1× 3.9k 1.4× 1.8k 0.9× 1.9k 1.1× 416 12.6k
Michael Tymianski Canada 58 5.8k 1.5× 3.2k 0.8× 5.9k 2.1× 2.5k 1.3× 1.7k 0.9× 195 14.5k
Denis Vivien France 63 3.8k 1.0× 2.0k 0.5× 2.4k 0.8× 3.3k 1.7× 1.4k 0.8× 323 12.4k
Esther Shohami Israel 64 5.0k 1.3× 4.3k 1.1× 3.0k 1.1× 2.1k 1.1× 2.1k 1.2× 238 14.7k

Countries citing papers authored by Hideki Mochizuki

Since Specialization
Citations

This map shows the geographic impact of Hideki Mochizuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Mochizuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Mochizuki more than expected).

Fields of papers citing papers by Hideki Mochizuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Mochizuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Mochizuki. The network helps show where Hideki Mochizuki may publish in the future.

Co-authorship network of co-authors of Hideki Mochizuki

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Mochizuki. A scholar is included among the top collaborators of Hideki Mochizuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Mochizuki. Hideki Mochizuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdelhamid, Rehab F., Atsushi Kadowaki, Kotaro Ogawa, et al.. (2025). TDP-43 transports ferritin heavy chain mRNA to regulate oxidative stress in neuronal axons. Neurochemistry International. 184. 105934–105934. 1 indexed citations
2.
Takeuchi, Toshihide, Nobuhiro Fujikake, Mari Suzuki, et al.. (2024). Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD. Acta Neuropathologica Communications. 12(1). 20–20. 11 indexed citations
3.
Kaneko, Takaaki, Jumpei Matsumoto, Xincheng Zhao, et al.. (2024). Deciphering social traits and pathophysiological conditions from natural behaviors in common marmosets. Current Biology. 34(13). 2854–2867.e5. 4 indexed citations
4.
Ikenaka, Kensuke, Yuta Kajiyama, Chi‐Jing Choong, et al.. (2024). Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients. Pharmacology Research & Perspectives. 12(1). e1174–e1174. 6 indexed citations
5.
Takata, Kazushiro, Makoto Kinoshita, Daisuke Motooka, et al.. (2023). Food additive succinate exacerbates experimental autoimmune encephalomyelitis accompanied by increased IL-1β production. Biochemical and Biophysical Research Communications. 656. 97–103.
6.
Gon, Yasufumi, Ling Zha, Tsutomu Sasaki, et al.. (2023). Heart Disease Mortality in Cancer Survivors: A Population‐Based Study in Japan. Journal of the American Heart Association. 12(23). e029967–e029967. 7 indexed citations
7.
Sasaki, Tsutomu, Hiroo Tanaka, Hideaki Kanki, et al.. (2023). The tight junction protein occludin modulates blood–brain barrier integrity and neurological function after ischemic stroke in mice. Scientific Reports. 13(1). 2892–2892. 58 indexed citations
8.
Kawano, Tomohiro, et al.. (2023). Role of Polymorphonuclear Myeloid‐Derived Suppressor Cells and Neutrophils in Ischemic Stroke. Journal of the American Heart Association. 12(6). e028125–e028125. 7 indexed citations
9.
Nakamori, Masayuki, Daisaku Nakatani, Toshio Saito, et al.. (2023). Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. EClinicalMedicine. 67. 102390–102390. 7 indexed citations
10.
Ikenaka, Kensuke, Yasuhiro Maeda, Yuji Hotta, et al.. (2022). Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis. European Journal of Neurology. 29(5). 1410–1416. 6 indexed citations
11.
Yamaguchi, K., Masatomo So, Eri Chatani, et al.. (2021). Breakdown of supersaturation barrier links protein folding to amyloid formation. Communications Biology. 4(1). 120–120. 47 indexed citations
12.
Revankar, Gajanan S., Yuta Kajiyama, Noriaki Hattori, et al.. (2021). Prestimulus Low-Alpha Frontal Networks Are Associated with Pareidolias in Parkinson's Disease. Brain Connectivity. 11(9). 772–782. 7 indexed citations
13.
Kawano, Teiji, Noriaki Hattori, Yutaka Uno, et al.. (2021). Association between aphasia severity and brain network alterations after stroke assessed using the electroencephalographic phase synchrony index. Scientific Reports. 11(1). 12469–12469. 14 indexed citations
14.
Todo, Kenichi, Toshiaki Sasaki, Nobuyuki Ohara, et al.. (2020). A multicenter study of transient global amnesia for the better detection of magnetic resonance imaging abnormalities. European Journal of Neurology. 27(11). 2117–2124. 16 indexed citations
15.
Nakamori, Masayuki, Eunsung Junn, Hideki Mochizuki, & M. Maral Mouradian. (2019). Nucleic Acid–Based Therapeutics for Parkinson's Disease. Neurotherapeutics. 16(2). 287–298. 43 indexed citations
16.
Yamashita, Kazuya, Makoto Kinoshita, Katsuichi Miyamoto, et al.. (2018). Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder. Journal of Neuroinflammation. 15(1). 125–125. 18 indexed citations
17.
Beck, Goichi, Koei Shinzawa, Hideki Hayakawa, et al.. (2016). Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A2β Knockout Mice. PLoS ONE. 11(4). e0153789–e0153789. 10 indexed citations
18.
Gon, Yasufumi, Shuhei Okazaki, Yasukazu Terasaki, et al.. (2016). Characteristics of cryptogenic stroke in cancer patients. Annals of Clinical and Translational Neurology. 3(4). 280–287. 64 indexed citations
19.
Kitamura, Eiji, Junichi Hamada, Naomi Kanazawa, et al.. (2010). The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neuroscience Research. 68(2). 154–157. 44 indexed citations
20.
Matsunari, Hitomi, Masafumi Onodera, Norihiro Tada, et al.. (2008). Transgenic-Cloned Pigs Systemically Expressing Red Fluorescent Protein, Kusabira-Orange. Cloning and Stem Cells. 10(3). 313–324. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026